Podcasts about Overweight

Technology has significantly changed the world we live in. One of the areas it's changed is sporting events. Back in the day, we watched teams battle it out on weary-looking grass under incandescent flimsy filament bulbs on pixelated screens with clunky rotary knobs. Overweight and out of shape, umpires and referees were forced to make split-second decisions with no backup, inevitably leading to the cheers of fans positively impacted and the boos of fans who felt ill-treated!Today, we have instant replay scrubbing every angle of every play, reviewed on LED screens by officials stopping the game to review the action and make the absolutely correct call. Guess what, even with the latest and greatest tech, we sit back and question every call made in light of which team we prefer. He was out! That goal counted! Foul! NO FOUL!In this message, we continue our journey through the Exodus account, looking at the Red Sea. God's victory over the enemy is decisive, final, and resolute! No questions should remain, but somehow they persist! This weekend, we will be reminded of the powerful Savior, JESUS CHRIST, who is more than able to set us free from bondage and lead us into new life, with no room to question the result.Pastor Matt McCarter

Coming up, Wegovy weight loss pills are now available in pharmacies and online in the UK. Will they help tackle obesity? Plus, how scientists are trying to restore sensation in the feet; the legacy of Dolly the sheep 30 years on; and space rovers and the solar eclipse with the astronomer Megan Argo. Like this podcast? Please help us by supporting the Naked Scientists

The  Moose on The Loose helps Canadians to invest with more conviction so they can enjoy their retirement. Today, we talk about the dilemma of paying capital gains taxes on a big position or holding it to avoid paying taxes. It's all about Dividend growth investing! Subscribe to the best free dividend investing newsletter: https://thedividendguyblog.com/newsletter Get the 20 income products guide for retirees: https://retirementloop.ca/income/

For years, Andy felt stuck.Overweight, frustrated, constantly weighing himself, and repeatedly returning to keto, he believed he just needed more discipline and more effort.So he worked harder.He tracked more.He exercised 6 days per week.And yet the results never seemed to last.In this powerful conversation, Andy shares how he broke free from the all-or-nothing mindset, learned to trust the small steps, and finally created a sustainable approach that led to big weight loss success! Whether you're a man struggling to get started . . .Or someone who's tired of starting over . . . This episode is packed with practical wisdom and insights that will help you find the success you want. We'll explore:What Andy wishes he knew years agoWhy keto seemed to work (until it didn't)How scale obsession was affecting his mindset Why working out more wasn't solving the problemHow he now approaches vacations without regaining weightWhat sustainable weight loss actually looks like in real life!While this conversation is especially valuable for men over 40, the principles Andy shares apply to anyone who's tired of chasing quick fixes and ready to build lasting results.Join Corey's Email Newsletter: https://LoseFatList.comANTI-DIET CLASS: https://AntiDietClass.com

Carl Quintanilla, Jim Cramer and David Faber covered a busy hour on the tech front: David reports Amazon plans to raise $25 billion in a bond sale according to sources; Chip stocks under pressure despite Samsung's record quarterly results; Several Wall Street analysts initiate coverage of SpaceX with "Buy" or "Overweight" ratings — as the stock makes its debut on the Nasdaq 100. Also in focus: A fresh record high for the Dow, oil prices rise on reports tankers were attacked in the Strait of Hormuz, President Trump in Turkey at the NATO summit, Walmart announces price cuts on thousands of items, Cramer on the consumer names he says are worth buying now, Nvidia and Apple battle for title of most valuable company.   Squawk on the Street Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

It's In the News - a look at the top diabetes headlines and stories happening now. Our top stories: More information about type 1 and COVID, including the vaccine, why is the latest GLP-1 medication, not yet FDA approved, showing up all over the place, what table sugar and vinegar could mean for drug costs, a new inhaled insulin study and much more  I'll see you at Friends for Life next week. Come find me at Table T18 Learn more about our in-person events here: https://diabetes-connections.com/events/ Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Transcript & links:    Okay.. our top story this week: XX A large Swedish study found that the increased risk of being diagnosed with type 1 diabetes after COVID-19 infection is mostly limited to the first 30 days after infection and does not continue long term. Researchers followed nearly the entire Swedish population under age 80 from 2020 through 2023 and found that while SARS-CoV-2 infection was linked to a temporary rise in new type 1 diabetes diagnoses, the risk declined over time. The study also found no evidence that COVID-19 vaccination increases the long-term risk of developing type 1 diabetes. Vaccination did not significantly change the relationship between COVID-19 infection and diabetes risk, and any small increase in diagnoses seen among adults shortly after a first vaccine dose was not seen after later doses or during longer follow-up. The researchers concluded that their findings do not support changing current COVID-19 vaccination recommendations because of concerns about type 1 diabetes risk. https://www.infectiousdiseaseadvisor.com/news/covid19-infection-may-increase-short-term-type-1-diabetes-risk/ XX Two new studies are challenging the traditional view that type 1 diabetes develops solely because the immune system attacks insulin-producing beta cells. Researchers from Indiana University found evidence that beta cells themselves may play an active role in determining whether they survive or succumb to the stresses that lead to type 1 diabetes. In the first study, scientists discovered that some healthy human beta cells can quickly activate an antiviral defense system when exposed to interferon-alpha, an immune signal often produced during viral infections. This response relies on molecules called reactive oxygen species (ROS), which are usually associated with cell damage but, in this case, appeared to help switch on protective antiviral genes. Researchers found this defense program in healthy cells and in people at risk for type 1 diabetes, but not in beta cells from people who already had the disease. The findings suggest that losing this built-in defense mechanism may make beta cells more vulnerable during the development of type 1 diabetes. The second study focused on autophagy, the process cells use to recycle damaged or worn-out components. Using a new imaging technique, researchers observed that beta cells in a mouse model of type 1 diabetes showed defects in autophagy before blood sugar levels began to rise and even before a full immune attack was underway. This suggests that problems inside the beta cells may occur early in the disease process rather than being caused entirely by the immune system. Together, the studies point to a more complex picture of type 1 diabetes. While they do not show that beta-cell defects cause the disease, they suggest that differences in how beta cells respond to stress, viral signals, and cellular damage may influence who develops type 1 diabetes and how the disease progresses. https://medicalxpress.com/news/2026-06-beta-cells-players-diabetes.html XX Researchers have created the most detailed map yet of how the human pancreas develops during childhood, offering new clues about why children are especially vulnerable to developing diabetes. The study, published in Nature Communications, examined pancreatic tissue from 123 children without diabetes, ranging from newborns through age 10. Using advanced imaging techniques, scientists tracked how insulin-producing islet cells grow and mature during the first decade of life. The researchers found that pancreas size varies dramatically at birth, with some infants having pancreases nearly four times larger than others. They also discovered that insulin-producing beta cells grow more slowly after birth than previously thought, suggesting that much of a person's lifelong beta cell capacity may be established before birth and during early childhood. Other findings showed that insulin-producing cells mature earlier than glucagon-producing cells and that new hormone-producing cells may continue to form after birth. The researchers hope this new understanding of pancreas development will help scientists identify diabetes risk earlier and develop better strategies for prevention and treatment in children. https://news.vumc.org/2026/06/29/unlocking-diabetes-secrets-pediatric-organ-donors-help-map-a-path-to-a-cure-and-prevention/   XX At the American Diabetes Association annual meeting, 2-year results from the SUPPRESS-EARLY trial showed that initiating tirzepatide (Mounjaro, Zepbound) early in the course of type 2 diabetes led to substantially higher rates of near-normal glycemic control and also led to broader metabolic improvements compared with intensive conventional therapy.   In this MedPage Today video, investigator Stefano Del Prato, MD, of the University of Pisa in Italy, discusses the findings.     Following is a transcript of his remarks:   What happened is that in the tirzepatide-treated arm, 85% of the population at the end of the second year was on the maximum dose of tirzepatide 15 mg. And then the remaining 15 with the different doses.   Interestingly, in the population that had been treated with the intensive conventional approach, 85% of them ended up to have, on top of metformin, a GLP-1 receptor agonist, mainly represented by subcutaneous semaglutide [Ozempic, Wegovy], 60+%, another 15% on oral semaglutide [Rybelsus], and the remaining on dulaglutide [Trulicity].   And I have to say that maybe the recommendation to really push along the line to try to achieve and to strive to achieve [glycemic] control was successful in these individuals. Because the population that had been recruited in the study started off with a baseline A1C of 7.8% and it went down to 6.3% in the conventionally intensive treatment, which is not bad at all, on average is below the target of 6.5%.     However, when we look at the effect of tirzepatide, the final level of A1C at the end of the second year was 5.6%, which is on average below the upper limit of the normal range for A1C, 5.7%. This also translates into more people not only achieving normal glycemia, if we can define normal glycemia as A1C below 5.7%, greater than what we observed in conventionally treated individuals. So it was around three times more people achieving an A1C of 5.7%, in the range of around 65%, as compared to 28% with people on a conventional optimized treatment.   Now, this is not surprising knowing the potency of tirzepatide. But again, going back to the rationale of the design, can we change what is the natural history of the disease? This seems to be at least of interest and it's possibly changing the trajectory of the disease for glycemic control, as I mentioned, but also in terms of the body weight and waist circumference because both body weight and waist circumference went much lower with tirzepatide compared to the conventional treatment.   Tirzepatide also was associated with an improvement in the lipid profile, in particular with the LDL, triglycerides, and the triglyceride concentration and non-HDL cholesterol, and also with a statistically significantly lower systolic blood pressure with a numerical reduction in the diastolic blood pressure.   And also the other thing that probably will ... become more apparent with the study continuing is that the investigators were allowed to add on any other treatment ... needed to achieve their target. So tirzepatide was just metformin and tirzepatide. In the control group, there was already 10% of people who were receiving two drugs on top of the metformin.   So another potential result of the trial is that it's possible to achieve and maintain better glycemic or better metabolic control over the time without really needing to increase the number of medications in order to achieve that goal. And we know that type 2 diabetes is a progressive condition often requiring intensification of the treatment.   So these initial results really stand for a great opportunity with tirzepatide. Of course, we need to wait for the 4 years just to confirm that this is indeed the case, but the initial result seems to point along that line. https://www.medpagetoday.com/meetingcoverage/adavideopearls/121967 XX A study from the University of Virginia found that high blood pressure is extremely common among people with diabetes, even among those who believe their blood pressure is under control. Researchers measured blood pressure in 172 adults with type 1 or type 2 diabetes during routine eye clinic visits and found that only 8% had normal readings. About half had stage 2 hypertension, and more than 10% had blood pressure levels high enough to be considered a medical emergency. The study also revealed that many patients were unaware of how serious their blood pressure problems were. Among those who thought their hypertension was well controlled, more than half still had stage 2 hypertension. Nearly 60% of participants were advised to contact their primary care provider, and one patient required an emergency department referral. Most patients supported blood pressure screening during eye exams, leading researchers to suggest that routine blood pressure checks in ophthalmology clinics could help identify undiagnosed or poorly controlled hypertension before it leads to serious complications such as heart attack, stroke, or worsening diabetic eye disease. https://medicalxpress.com/news/2026-06-routine-eye-exams-reveal-stage.html XX What is going on with retatrutide? This is the next generation GLP-1 but it's not authorized outside of clinical trials. Big investigation by CBS shows retatrutide is for sale all over the internet, a phenomenon they say has no modern precedent. CBS News identified more than 120 websites selling or promoting retatrutide, including more than 50 clinics staffed by licensed medical professionals. After being contacted by CBS News, at least 21 clinics abruptly removed retatrutide from their websites or changed the language to state they don't offer it. Others defended prescribing it, saying they're confident enough in results from clinical trials sponsored by drugmaker Eli Lilly that they didn't need to wait for the FDA's independent, rigorous review. An FDA spokesperson said retatrutide "has not been found safe or effective for any condition," adding that it "cannot be manufactured or distributed except for investigational use." The Justice Department is prosecuting two cases – in Utah and Florida – involving the sale and prescription of retatrutide. But the first line of enforcement is often at the state level. Ohio's Board of Pharmacy has taken action against several pharmacies and clinics providing retatrutide, and just last month, Alabama's Medical Board warned physicians against prescribing research-grade medications. The FDA has sent 14 warning letters to companies that have advertised retatrutide since 2024. Of these, at least six have continued to offer it online, including a business called Pink Pony Peptides. A TikTok account associated with the firm responded to the warning in April by taunting the FDA, boasting that the business "just had the best 24 hours ever." In May, Eli Lilly announced that participants in a large clinical trial taking the highest dose of retatrutide lost an average of 28% of their body weight over 80 weeks. Side effects – including nausea, diarrhea, constipation and vomiting – were comparable to similar therapies, the company said. "Anyone purporting to sell retatrutide to consumers is breaking the law," an Eli Lilly spokesperson said https://www.cbsnews.com/projects/2026/experimental-weight-loss-drug/ XX Pioneering research has developed a new way of creating carbohydrate-based medicines, which could ultimately replace costly drugs for common health conditions, using two cheap basic ingredients – table sugar and vinegar. These medications include SGLT2 inhibitors, widely prescribed drugs used to treat type 2 diabetes, heart failure and chronic kidney disease. Co-lead author Professor Phil Baran, Dr. Richard A. Lerner Endowed Chair at Scripps Research, in San Diego, California, said: "The point of this is to show that anyone in a garage can make an SGLT2 inhibitor with reagents that are widely available. We have not patented this method, so we welcome any generic drug company – or anyone else – who wants to use it to help bring costs down for patients." https://www.newswise.com/articles/new-study-shows-table-sugar-could-hold-a-cheaper-quicker-key-to-making-vital-drugs-for-diabetes-heart-failure-and-chronic-kidney-disease XX England and Wales approve teplizumab to slow progression of T1D. At the moment, the Scottish Medicines Consortium does not have an appraisal of Tzield on the go, so, there is likely to be a disparity in access within the UK for the time being. In Northern Ireland, access will depend on a review and adoption of NICE guidance.  Sanofi is expecting to see an uptick in momentum thanks to two subsequent FDA approvals, one in children as young as one with stage 2 T1D, and a second to delay the decline in endogenous insulin production in children aged eight to 17 years recently diagnosed with stage 3 T1D. btw you might here more people referring to stage 4 diabetes. They've added that to include people diagnosed with type 1 who've been on insulin for a longer period of time – basically long enough to not be eligible for the current guidelines for Tzield. https://www.bbc.com/news/articles/ce8mzd94r76oXX XX Obesity Association, a division of the American Diabetes Association® (the association), announced the next section in the Standards of Care in Overweight and Obesity, "Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults," published in Diabetes, Obesity, and CardioMetabolic CARE® and BMJ Open Diabetes Research & Care.  Key highlights of the guidance: Early screening: Annual BMI screening with emphasis on tracking weight trends to identify risk earlier, including a longitudinal life-event weight graph tool for standardized assessment. Enhanced diagnosis: Combines BMI with waist measurements and population-specific thresholds to improve accuracy. Notably, the guidelines recommend that BMI in the overweight range together with central adiposity measurements warrant a formal obesity diagnosis. Comprehensive evaluation: Holistic assessment including medical, behavioral, and social factors. Offers a fully integrated obesity diagnostic algorithm. Risk stratification: Use of tools like the Edmonton Obesity Staging System to guide care. Chronic care approach: Ongoing monitoring and follow-up to support long-term management. Reducing bias: Promotes person-centered, non-stigmatizing care and system-level improvements at the clinical workflow level and encourages screening for prior weight bias/stigma experiences. https://www.prnewswire.com/news-releases/new-standards-of-care-in-overweight-and-obesity-section-screening-diagnosis-evaluation-and-staging-of-obesity-in-adults-302809670.html XX Dexcom (Nadsaq:DXCM) today announced the launch of its fully reimagined Stelo over-the-counter (OTC) sensor app experience. San Diego-based Dexcom plans to formally begin the new app rollout in July for Apple iPhone and Android users in the U.S. Dexcom said its reimagined app aims to make glucose insights easier to understand and act on. It hopes to help build awareness of how food, activity, sleep and stress influence overall wellbeing.   The company also reiterated plans to launch Stelo internationally. It expects to bring the sensor to the UK, Australia, New Zealand and South Korea later this year, continuing into 2027. https://www.drugdeliverybusiness.com/dexcom-launches-enhanced-stelo-app/ XX MannKind Corporation recently announced it received a grant from Breakthrough T1D to support the INHALE-1 clinical study of Afrezza, its ultra rapid-acting inhaled insulin, in newly diagnosed pediatric type 1 diabetes patients aged 10 to under 18 years. This external funding for a trial focused on early use of Afrezza in children highlights growing third-party support for inhaled insulin in pediatric diabetes care. https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mnkd/mannkind/news/afrezza-pediatric-trial-grant-might-change-the-case-for-inve XX Alexander Zverev heads into Wimbledon with plenty of momentum. The French Open champion returns to the All England Club looking to build on his first Grand Slam title and gain ground on Carlos Alcaraz in the race for the No. 2 spot in the ATP rankings. Zverev has an opportunity to make up points quickly after a first-round exit at Wimbledon last year. But his final tune-up before Wimbledon came with an unexpected challenge. During his semifinal loss to Taylor Fritz at the Halle Open, Zverev said a malfunctioning glucose sensor led to serious diabetes management issues on court. The sensor incorrectly showed his blood sugar was high when it was actually low, causing him to take more insulin than needed. "I had huge problems with the sugar because the sensor I use gave me a completely incorrect reading," Zverev said after the match. "During the match, or rather during the first 45 minutes, I had to consume about 350 grams of sugar. I felt absolutely terrible." Despite feeling unwell, Zverev pushed the match to three sets before falling 6-7(4), 6-4, 7-5 to Fritz. He credited his opponent with playing the better match and said the diabetes-related issue was not an excuse for the result. Zverev, who was diagnosed with type 1 diabetes at age 4, uses Medtronic diabetes technology to help manage his glucose levels while competing on the ATP Tour. He said the sensor error was the first major problem he has experienced after nearly a decade of using the technology. The German said the incident should not affect his Wimbledon preparations. With the sensor issue behind him, Zverev will begin his Wimbledon campaign focused on adding another strong result to what has already been a breakthrough season.   https://www.reuters.com/sports/tennis/zverev-says-glucose-sensor-malfunction-affected-halle-semi-final-loss-fritz-2026-06-21/

Strength training is among the best things you can do to improve your health, and that goes for both adults and children. But what kind of effects does strength training have on children who are overweight or obese? In today's episode, we're discussing a new study review looking into exactly this – and the results are encouraging! *** Do you like what you hear so far? Please leave a five-star review in your podcast player. And hit that follow button! You can also follow us on Instagram. You'll find Daniel at @strengthdan, and Philip at @philipwildenstam. Become a part of our Reddit community here. *** This podcast is brought to you by Styrkelabbet AB, Sweden. To support us, download the world's best gym workout tracker app StrengthLog here. It's completely ad-free and the most generous fitness app on the market, giving you access to unlimited workout logging, lots of workouts and training programs, and much, much more even if you stay a free user for life. If you want a t-shirt with "Train hard, eat well, die anyway", check out our shop here.

In this episode, we sit down with Jade Guerra to discuss hypothyroidism, Type 2 diabetes, and the seven organs that play a critical role in blood sugar regulation. As a chiropractor and nurse practitioner with expertise in functional medicine, Dr. Guerra takes a comprehensive approach to health – helping patients uncover and address the underlying factors that contribute to chronic conditions rather than simply managing symptoms… Drawing from her unique blend of clinical training and holistic wellness strategies, Dr. Guerra works to help individuals improve metabolic health, restore balance, and make sustainable lifestyle changes that support long-term well-being. Hit play to discover: The seven organs involved in regulating blood sugar levels How hypothyroidism and blood sugar imbalances can be interconnected The role of lifestyle and nutrition in supporting metabolic health How reducing toxic exposures may contribute to overall wellness Want to learn more about the root causes of blood sugar dysfunction and thyroid-related health challenges? Join the conversation as Dr. Guerra shares her integrative approach to helping patients achieve better health through nutrition, lifestyle modifications, and personalized care. Connect with Dr. Guerra: Website Instagram YouTube X Tiktok

Nutrition Nugget! Bite-sized bonus episodes offer tips, tricks and approachable science. This week, Jenn is talking about meals on repeat and whether eating the same foods over and over aids in weight loss. A new study claims that less variety in your diet is associated with better results, but is that the full picture? Jenn dives into the research, the numbers, and what they really mean, while questioning whether a 12-week study tells the whole story. Does sticking to the same meals set you up for long-term success, or could it backfire down the road? Tune in to hear Jenn break it all down and find out what she really thinks. Like what you're hearing? Be sure to check out the full-length episodes of new releases every Wednesday. Have an idea for a nutrition nugget? Submit it here: https://asaladwithasideoffries.com/index.php/contact/RESOURCES:Become a Happy Healthy Hub MemberJenn's Free Menu PlanA Salad With a Side of FriesA Salad With A Side Of Fries MerchA Salad With a Side of Fries InstagramKEYWORDS: Jenn Trepeck, Nutrition Nugget, Salad With A Side Of Fries, Health Tips, Wellness Tips, Meals on Repeat, Weight Loss Research, Weight Loss Tips, Weight Loss, Meal Planning, Dietary Repetition, Caloric Stability, Calorie Tracking, Behavioral Weight Loss, MyFitnessPal, Food Logs, Weight Loss Program, Health Psychology, BMI, Overweight, Obesity, Meal Prep, Healthy Eating, Nutrition Tips, Wellness Coach, Diet Routine, Food Variety, Repetitive Meals, Self Control, Weekend Eating Habits, Weekday Eating Habits, Correlation Vs Causation, Diet Studies, Sustainable Weight Loss, Yo Yo Dieting, Healthy Habits, Food Tracking, Calorie Deviation, Diet Boredom, Real Food Coaching, Weight Loss Strategies, Nutrition Myths, Diet Research, Eating Patterns, Salad With A Side Of Fries, Jenn Trepeck, Health Coaching, Body Weight Management, Does Eating The Same Meals Help You Lose Weight, Benefits Of Meal Repetition For Weight Loss

As we enter H2 2026, Manpreet Gill and Ray Heung assess where global markets are heading and what investors should focus on. They outline their reasons for remaining Overweight equities, share their latest views on fixed income and conclude with a discussion on gold. Listen to the full conversation to stay ahead of market shifts.You can read our latest Global Market Outlook today here.Speaker(s):- Manpreet Gill, CIO of Africa, Middle East & Europe (AME/E), Standard Chartered Bank - Ray Heung, Senior Investment Officer,  Standard Chartered Bank For more of our latest market insights, visit Market views on-the-go or subscribe to Standard Chartered Wealth Insights on YouTube.

In this episode, Dr. Thomas Hemingway shares the Truth about Metabolism, what the Data Actually Shows, and it's likely not what you've heard because most people and doctors think our metabolism slows down as we age. The data says differently.  And he explains how you can reverse this and get your metabolism back, running stronger, smoother and cleaner than ever before.  Have a Listen and Share with a Friend!**Free PDF:  "How to Optimize your Metabolism in 7 Easy Steps."   Inside the PDF, we pull back the curtain on how to actually get your metabolism Super-charger and running better than ever before.*And, in my new Performance, and Longevity medical practice we specialize in turning back your biological age and OPTIMIZING HORMONES so you can feel a decade or more younger so you can do the things you want to do that you thought were no longer possible due to your age.  Join the waitlist here!*Don't wait to Prioritize your health, Start Today with the Simple and Powerful Steps detailed in my Best-selling book, PREVENTABLE.*ACCESS my FREE workshop, "GET 10 Years Younger, Stronger, and Sharper"  How to turn back your biological age 10-20 years so you can do the things you want to do that you no longer thought possible due to your age.  Perform at your best and live your best life!Join my Free Masterclass on Midlife Hormones, "Why You Don't Feel like Yourself anymore and What to Do about it!"JET LAG Survival Guide.  Free PDF!*GET DIRECT ACCESS to DR. HEMINGWAY in these AMAZING COURSES!**Free Resource:  "The 7 lab tests your doctor likely is not checking and could be the key to why you don't feel your best." *Don't Forget to SHARE with a Friend and please drop a Review:) It means the world!Mahalo and Aloha andTo your health,

The labor market improving is the crux to the U.S. economy finding its footing, says Ryan Detrick, even though markets showed a lot of negative price action throughout Tuesday's session. He analyzes how it buoys against rising inflation and explains why he's still overweight equities compared to bonds. ======== Schwab Network ========Empowering every investor and trader, every market day.Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

More than half of U.S. dogs and cats are overweight or obese—but the reasons go beyond table scraps and too many treats. Dr. Ernie Ward, founder and president of the Association for Pet Obesity Prevention, says the issue is far more complex, and in cats, the link between obesity and diabetes has reached epidemic levels. […]

Binge Eating: She Chose Being Overweight Because She Thought It Would Be Easier [Podcast #696 ] Original copyrighted content published February 19, 2026 at https://fearlessfatloss.com/podcast/binge-eating-she-chose-being-overweight-because-she-thought-it-would-be-easier © 2026-Present JoLynn Braley International LLC

Cara came to me in 2020, thinking she needed to lose weight. She was 52, stuck in survival mode, and convinced her best years were behind her. She'd given up. But what happened over the next six years wasn't about macros or meal plans. It was about rebuilding her identity from the inside out.Today she's 58, leading one of the fastest-growing fitness franchises in the country, and proving that your life doesn't end just because you're not 25 anymore. If you think it's too late for you, this one's gonna hit different.Support the showHosted by Casey Shipp — 3000+ transformations, Self-Made Millionaire, High Priestess, Writer, Fitness Cover Model, and Founder of the Hotbody App.$30M client wins | $7.8M sold onlineRich isn't rare. Category of one is.

Hour 3 opens with discussion around reports questioning De'Von Achane's weight as he prepares to speak to the media, with Joe Rose dismissing the concern while also noting similar chatter around Dolphins first-round pick Kenneth Grant. The conversation then shifts to Miami Heat basketball as Ira Winderman joins to break down the Jimmy Butler era, calling him a “diva” at times while still acknowledging his superstar impact, and detailing how Miami could realistically assemble a package for Giannis Antetokounmpo that would likely include multiple prospects and the 13th pick. Winderman also discusses alternative star targets like Ja Morant and Kawhi Leonard, the development of Nikola Jovic and Kel'el Ware, and the stability of the Riley–Spoelstra relationship. The hour closes with NBA Playoffs talk and a broader discussion on some of the ugliest breakups in Miami sports history, including Jimmy Butler, Richie Incognito, Jalen Ramsey, and others.

Joe Rose shares another wild old-school Dolphins story from the 1980s involving players putting Bengay in a cake as a prank that left a teammate throwing up after taking a bite. The conversation then shifts to current Dolphins OTAs, where running back De'Von Achane is expected to speak to the media following his recent contract extension. Joe reacts strongly to comments from Omar Kelly suggesting Achane showed up to camp looking a little heavy and also sounds off on Omar's previous take that the Dolphins should bring back Christian Wilkins. Plus, the crew briefly revisits whether the Heat could realistically land Giannis Antetokounmpo this offseason.

Send us Fan MailIn this episode I talk about something that many parents worry about, but very few feel comfortable discussing openly.What do you do when you feel like your child is overweight?Thanks for listening, I hope this episode will be helpful.Philippe

Manpreet Gill (CIO, AMEE) and Ray Heung (Senior Investment Strategist) discuss how US Q1 2026 earnings support our Overweight view on equities, especially in the tech sector. They also examine the rationale for adding gold miners to portfolios, the USD/JPY outlook amid central bank policy divergence and selective opportunities in GCC Investment-grade sovereign and bank bonds.You can read our latest Global Market Outlook today here.Speaker(s):- Manpreet Gill, CIO of Africa, Middle East & Europe (AME/E), Standard Chartered Bank - Ray Heung, Senior Investment Officer,  Standard Chartered Bank  For more of our latest market insights, visit Market views on-the-go or subscribe to Standard Chartered Wealth Insights on YouTube.

Legendary Miami Dolphins wide receiver Oronde Gadsden joined the show to share his thoughts on the Dolphins draft picks and his experience of having a weight clause in his contract with the Dolphins.

These shows are made possible by your support on Patreon.com/RapReviews. RapReviews.com and MarksOfWrestling.com share the same server for hosting so any support for either site would be appreciated. Thank you!

Are you doing everything right, eating well, exercising, sleeping, and still watching your belly grow and your energy disappear? Or maybe you've heard that menopause changes your metabolism, but nobody's actually explained what that means or what to do about it? Today I talk with Dr. Siobhan Mitchell, one of the leading researchers on mitochondria, metabolism, and women's health. We cover: Why losing estrogen literally rewires how your body uses and stores energy What happens to your gut microbiome as you transition into menopause  What GLP-1 medications are doing to your metabolism and muscle that no one talks about A little-known molecule that is a powerful estrogen mimetic that few have heard of  What actually supports hormonal metabolic health in midlife beyond diet and exercise   Siobhan Mitchell is the chief scientific officer of MitoQ. She completed her PhD at SUNY Albany and a post-doctoral fellowship on brain aging. Siobhan held roles at the three largest food companies in the world (Unilever, Nestle and Pepsico), leading trials in Europe, North America and Asia, which investigated the effects of nutrition on cognitive decline, mood and performance. Additionally she was senior director at Noom, where she directed a team investigating chronic disease management, weight loss and mental health digital programs using cognitive behavior therapy methods. Siobhan has authored over 80 papers, and holds eight patents for aging, cognition and mood products.   Code ZORA for 10% off Hormonal Metabolic Control and other MitoQ products Contact Siobhan Mitchell Email: smitchell@mitoq.com Website: Mitoq.com Instagram: https://instagram.com/mitoq   Give thanks to our sponsors: Try Vitali skincare. 20% off with code ZORA here - https://vitaliskincare.com Get Primeadine spermidine by Oxford Healthspan. 15% discount with code ZORA ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ - https://www.oxfordhealthspan.com/ZORA Get Mitopure Urolithin A by Timeline. 20% discount with code ZORA at https://timeline.com/zora Try MitoQ for optimal mitochondrial health. Code ZORA for 20% off https://mitoq.com/zora   Build Strong Bones Masterclass April 25, 2026 https://mailchi.mp/hackmyage/vdrp7df21q Join the Hack My Age community on: YouTube: https://youtube.com/@hackmyage Facebook Page: ⁠⁠⁠⁠⁠@⁠Hack My Age⁠     Facebook Group: ⁠⁠⁠⁠⁠⁠@⁠Biohacking Menopause⁠⁠⁠⁠⁠⁠ ⁠   Biohacking Menopause Private Women's Only Support Group: https://hackmyage.com/biohacking-menopause-membership/ Instagram: ⁠⁠⁠⁠⁠@⁠HackMyAge⁠    Website: ⁠⁠⁠⁠⁠⁠HackMyAge.com⁠    For partnership inquiries: https://www.category3.ca/  Some episodes of Hack My Age are supported by partners whose products or services may be discussed during the show. The host may receive compensation or earn a minor commission if you purchase through affiliate links at no extra cost to you. All opinions shared are those of the host and guests, based on personal experience and research, and do not necessarily represent the views of any sponsor. Sponsorships do not imply medical endorsement or approval by any healthcare provider featured on this podcast.

What if your best decade is still ahead of you? At 62, broadcaster and healthy aging expert Liz Earle is fitter, stronger, and happier than ever.In this chat with Fearne, Liz shares how she went from overwhelmed, overweight, and exhausted during perimenopause, to thriving in her 60s. She shares the small lifestyle shifts that transformed her health, and why women in midlife shouldn't feel selfish moving themselves up the priority list.Fearne and Liz dig into the science of aging well, including the power of sunlight (and whether we should be wearing SPF year-round!), and why we should be prioritising sleep and strength training.Plus, what happened when Liz's younger boyfriend took her clubbing for the first time at 60 years old...?Liz's book, How To Age, is out now.Listen to Liz's podcast, Age Better, here!If you liked this episode of Happy Place, you might also like:Naomi WattsCallie BeatonPoorna Bell Hosted on Acast. See acast.com/privacy for more information.

Charles Bobrinskoy says the S&P 500's heavy tech concentration is giving investors a false sense of diversification, creating an opportunity in overlooked small-cap value stocks. He favors housing-exposed names MHK and REZI, consumer plays SJM and PHIN, MOS as an agriculture hedge, and suggests short-duration fixed income as inflation risks remain elevated.======== Schwab Network ========Empowering every investor and trader, every market day.Options involve risks and are not suitable for all investors. Before trading, read the Options Disclosure Document. http://bit.ly/2v9tH6DSubscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/About Schwab Network - https://schwabnetwork.com/about

In this episode of The Jordan Syatt Podcast, I speak with Gretchen, an incredible mother of a young boy who she told me is overweight and being bullied.We have a conversation in which I provide insight on what she can do to help him lose weight, improve his health, and increase his confidence.I hope you enjoy this episode and, if you do, please leave a review on iTunes (huge thank you to everyone who has written one so far).Finally, if you've been thinking about joining The Inner Circle but haven't yet... we have hundreds of home and bodyweight workouts for you and you can get them all at https://www.sfinnercircle.com/

GLP-1 medications like semaglutide and tirzepatide are everywhere right now—but are they actually solving the problem? In Episode 8 of this 16-part series on ultra-processed foods, Dr. Brendan McCarthy breaks down the truth about GLP-1 medications: how they work, why they can feel like a “miracle,” and where things go wrong when they're used without proper medical guidance. This isn't about shame. It's about understanding. GLP-1s can quiet “food noise” and help regulate appetite—but they don't fix your relationship with food, your metabolism, or the long-term patterns that lead to weight gain. Without structure, nutrition, and proper care, many patients end up with muscle loss, nutrient deficiencies, and rebound weight gain. In this episode, you'll learn: What GLP-1 medications actually do in your body Why they're not a long-term solution on their own The biggest mistakes doctors and clinics make when prescribing them How ultra-processed foods drive weight gain in the first place How to use GLP-1s the right way to create lasting change The goal isn't dependence—it's freedom. If you're currently on a GLP-1 (or considering it), this episode will change how you think about your treatment plan.   Mechanism Anchored References This episode is not anti medication. It is about putting GLP 1 therapy in its proper place. GLP 1 receptor agonists can reduce appetite pressure and alter satiety signaling. That matters. But quieter appetite is not the same as full recovery. Food quality still matters. Protein still matters. Muscle still matters. Structure still matters.   References U.S. Food and Drug Administration. WEGOVY semaglutide injection Prescribing Information. 2025. Wilding, John P H, et al. Once Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, vol. 384, no. 11, 2021, pp. 989 to 1002. Wilding, John P H, et al. Weight Regain and Cardiometabolic Effects After Withdrawal of Semaglutide The STEP 1 Trial Extension. Diabetes Obesity and Metabolism, vol. 24, no. 8, 2022, pp. 1553 to 1564. Hall, Kevin D, et al. Ultra Processed Diets Cause Excess Calorie Intake and Weight Gain An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake. Cell Metabolism, vol. 30, no. 1, 2019, pp. 67 to 77. Neeland, Ian J, et al. Changes in Lean Body Mass with Glucagon Like Peptide 1 Based Therapies and Mitigation Strategies. Diabetes Obesity and Metabolism, 2024. Wilding, John P H, et al. Impact of Semaglutide on Body Composition in Adults with Overweight or Obesity Exploratory Analysis of the STEP 1 Study. 2021. Everitt, Barry J, and Trevor W Robbins. Drug Addiction Updating Actions to Habits to Compulsions Ten Years On. Annual Review of Psychology, vol. 67, 2016, pp. 23 to 50. Monteiro, Carlos A, et al. The UN Decade of Nutrition the NOVA Food Classification and the Trouble with Ultra Processing. Public Health Nutrition, vol. 21, no. 1, 2018, pp. 5 to 17.   Dr. Brendan McCarthy is the founder and Chief Medical Officer of Protea Medical Center in Arizona. With over two decades of experience, he's helped thousands of patients navigate hormonal imbalances using bioidentical HRT, nutrition, and root-cause medicine. He's also taught and mentored other physicians on integrative approaches to hormone therapy, weight loss, fertility, and more. If you're ready to take your health seriously, this podcast is a great place to start.  

U.S.-Iran negotiations collapsed for now, but we see talks as evidence of an economic incentive to end the conflict. Wei Li, BlackRock Global Chief Investment Strategist, unpacks the case for dialing up risk. General disclosure: This material is intended for information purposes only, and does not constitute investment advice, a recommendation or an offer or solicitation to purchase or sell any securities, funds or strategies to any person in any jurisdiction in which an offer, solicitation, purchase or sale would be unlawful under the securities laws of such jurisdiction. The opinions expressed are as of the date of publication and are subject to change without notice. Reliance upon information in this material is at the sole discretion of the reader. Investing involves risks. BlackRock does and may seek to do business with companies covered in this podcast. As a result, readers should be aware that the firm may have a conflict of interest that could affect the objectivity of this podcast.In the U.S. and Canada, this material is intended for public distribution.In the UK and Non-European Economic Area (EEA) countries: this is Issued by BlackRock Investment Management (UK) Limited, authorised and regulated by the Financial Conduct Authority. Registered office: 12 Throgmorton Avenue, London, EC2N 2DL. Tel:+ 44 (0)20 7743 3000. Registered in England and Wales No. 02020394. For your protection telephone calls are usually recorded. Please refer to the Financial Conduct Authority website for a list of authorised activities conducted by BlackRock.In the European Economic Area (EEA): this is Issued by BlackRock (Netherlands) B.V. is authorised and regulated by the Netherlands Authority for the Financial Markets. Registered office Amstelplein 1, 1096 HA, Amsterdam, Tel: 020 – 549 5200, Tel: 31-20- 549-5200. Trade Register No. 17068311 For your protection telephone calls are usually recorded.For Investors in Switzerland: This document is marketing material.In South Africa: Please be advised that BlackRock Investment Management (UK) Limited is an authorised Financial Services provider with the South African Financial Services Board, FSP No. 43288.In Singapore, this is issued by BlackRock (Singapore) Limited (Co. registration no. 200010143N). This advertisement or publication has not been reviewed by the Monetary Authority of Singapore. In Hong Kong, this material is issued by BlackRock Asset Management North Asia Limited and has not been reviewed by the Securities and Futures Commission of Hong Kong. In Australia, issued by BlackRock Investment Management (Australia) Limited ABN 13 006 165 975, AFSL 230 523 (BIMAL). This material provides general information only and does not take into account your individual objectives, financial situation, needs or circumstances. Before making any investment decision, you should assess whether the material is appropriate for you and obtain financial advice tailored to you having regard to your individual objectives, financial situation, needs and circumstances. Refer to BIMAL's Financial Services Guide on its website for more information. This material is not a financial product recommendation or an offer or solicitation with respect to the purchase or sale of any financial product in any jurisdictionIn Latin America: this material is for educational purposes only and does not constitute investment advice nor an offer or solicitation to sell or a solicitation of an offer to buy any shares of any Fund (nor shall any such shares be offered or sold to any person) in any jurisdiction in which an offer, solicitation, purchase or sale would be unlawful under the securities law of that jurisdiction. If any funds are mentioned or inferred to in this material, it is possible that some or all of the funds may not have been registered with the securities regulator of Argentina, Brazil, Chile, Colombia, Mexico, Panama, Peru, Uruguay or any other securities regulator in any Latin American country and thus might not be publicly offered within any such country. The securities regulators of such countries have not confirmed the accuracy of any information contained herein. The provision of investment management and investment advisory services is a regulated activity in Mexico thus is subject to strict rules. For more information on the Investment Advisory Services offered by BlackRock Mexico please refer to the Investment Services Guide available at www.blackrock.com/mx©2026 BlackRock, Inc. All Rights Reserved. BLACKROCK is a registered trademark of BlackRock, Inc. All other trademarks are those of their respective owners.BII0426-5390407-EXP0427

Send us Fan MailThis week, I'm taking a curious, watch-and-see approach to GLP-1 medications—things like semaglutide, Ozempic, Wegovy. We'll cover the research-backed potential benefits, the side effects, what happens after stopping, and why the conversation is about much more than just weight. No judgment, no pressure, just information, reflection, and a reminder that your choices are personal and worth considering thoughtfully.Tune in if you want to explore GLP-1 medications from a place of curiosity and clarity.Quote of the Week:“We are what we repeatedly do. Excellence, then, is not an act, but a habit.” — Will Durant Citations1.    Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384, 989–1002.2.    Rubino, D., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance. Diabetes, Obesity and Metabolism.3.    SELECT Trial Investigators (2023). Semaglutide and Cardiovascular Outcomes in Obesity. New England Journal of Medicine.4.    Drucker, D. J. (2018). Mechanisms of Action and Therapeutic Application of GLP-1. Cell Metabolism.5.    Baggio, L. L., & Drucker, D. J. (2007). Biology of Incretins. Gastroenterology.Let's go, let's get it done.Get more information at: http://projectweightloss.org

Send us Fan MailMost people never look at the data. Not because it isn't available — because looking means the story might not survive.In this episode Greg Fearon breaks down the verdict loop: how a story about genetics, hormones, or biology closes the investigation before it starts, why the wellness industry profits every time that loop completes, and what actually shifts when a pattern gets named precisely enough that it can't be unseen. If you've done everything you were told to do and things still aren't falling into place  this episode is worth your time.

Peter Tchir is "highly suspect there will be a ceasefire" in Iran. Another 3% to 5% pullback in stocks is in the cards should the U.S.-Iran War escalate. When it comes to equities, Peter urges investors to turn overseas and look at sectors he sees growing as countries become more self-sufficient. He suggests staying long in the energy sector as geopolitical uncertainty and affordability issues last. ======== Schwab Network ========Empowering every investor and trader, every market day.Options involve risks and are not suitable for all investors. Before trading, read the Options Disclosure Document. http://bit.ly/2v9tH6DSubscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/About Schwab Network - https://schwabnetwork.com/about

Welcome back to our weekend Cabral HouseCall shows!   This is where we answer our community's wellness, weight loss, and anti-aging questions to help people get back on track!   Check out today's questions:    Darem: Hey, Dr Cabral. I recently did a health assessment where everything went well except my practioner telling me I'm overweight according to BMI which was 26.0. She then went off textbookedly (sic) saying to exercise more, eat more fruits & veggies etc. I already do all that for years. I'm 5'6, 161lbs, lean, muscular, 6 pack abs. Around 10% BF. How can I still be overweight      Jenny: Hi Dr. Cabral - I have a question about garlic. In a recent podcast you talked about the many benefits of garlic and of consuming at least a clove a day. Do we get the same great benefits of garlic (including cancer prevention) if it is cooked, roasted, baked as part of a recipe, etc., or does it need to be raw? (I know you talked about smashing it and letting it sit for 5 minutes.) Thank you!      Julie: Hi Dr. Cabral, My daughter (age 3 at the time) was diagnosed with Mycobacterium Avium Complex (MAC). It took awhile to properly diagnose and be treated since it is so rare in children. She was put on multiple medications including antibiotics for about 2 years (ethambutol, rifampin & azithromycin). She is now 9 and doing great, but we recently noticed symptoms of Raynaud's Syndrome. While I am waiting for an endocrinologist appointment I was hoping to see if you had any insight as to what would put her in a compromised state to begin with to be able to contract MAC. And now should I be testing and treating her with protocols to make sure her rain barrel isn't overfilling and if so what do you suggest at this young age?      Tricia: Hi Dr Cabral - hope you and the family are doing well! I have a quick question regarding the GLP Tone and Metavolve systems. I've done both and love them both! I am currently on Metavolve and have been for the last few months. I don't follow the diet plan it comes with strictly, but I do follow your baseline of a Mediterranean diet. I feel really good and am losing weight just more slowly. I'm 56 post-menopausal and am healing on the inside out. My question is can both of these systems be used long term? Are they safe to do so and when I do transition off of Metavolve do I need to do it slowly? Thank you for creating such amazing supplements to assist us in this life long journey of health!      Bob: Hello dr Cabral I wanted to ask for your thoughts on what might cause and what to do with this issue. I normally walk about 10k steps a day and either at mornings or nights have a longer walk about 5 to 6000 and make up the remaining steps throughout the day. But when taking the longer walk I have notice it seems my hands start to swell while walking. I have even noticed it in my wrist as my watch band gets very tight. I don't pump my arms very much when walking and feels harder to make a fist when this happens. Any advise on this for me. It does seem to go back to normal after stopping in few hours      Thank you for tuning into today's Cabral HouseCall and be sure to check back tomorrow where we answer more of our community's questions!    - - - Show Notes and Resources: StephenCabral.com/3711 - - - Get a FREE Copy of Dr. Cabral's Book: The Rain Barrel Effect - - - Join the Community & Get Your Questions Answered: CabralSupportGroup.com - - - Dr. Cabral's Most Popular At-Home Lab Tests: > Complete Minerals & Metals Test (Test for mineral imbalances & heavy metal toxicity) - - - > Complete Candida, Metabolic & Vitamins Test (Test for 75 biomarkers including yeast & bacterial gut overgrowth, as well as vitamin levels) - - - > Complete Stress, Mood & Metabolism Test (Discover your complete thyroid, adrenal, hormone, vitamin D & insulin levels) - - - > Complete Food Sensitivity Test (Find out your hidden food sensitivities) - - - > Complete Omega-3 & Inflammation Test (Discover your levels of inflammation related to your omega-6 to omega-3 levels) - - - Get Your Question Answered On An Upcoming HouseCall: StephenCabral.com/askcabral - - - Would You Take 30 Seconds To Rate & Review The Cabral Concept? The best way to help me spread our mission of true natural health is to pass on the good word, and I read and appreciate every review!  

Today we discuss housebreaking, overweight dogs, the correlation between the two, and why owners just can't accept that their dog is fat.

Ready to break through your Keto or low-carb plateau? Book a free consultation call with Robert Sikes here: https://www.ketobodybuilding.com/callMost people fail their fitness goals because they live in a state of restriction, not abundance. They believe hours in the gym and endless cardio are the keys to fat loss, but this approach often wrecks metabolism and leads to burnout. In episode 871 of the Savage Perspective Podcast, host Robert Sikes sits down with coach Martin Silva to reveal why building muscle is the true secret to sustainable fat loss and metabolic health. They discuss how to break the cycle of binge eating, why your leanest body isn't your healthiest, and how to build a resilient mindset that guarantees long-term success. This is your guide to building the powerful physique you want without destroying your relationship with food.Get Keto Brick: https://www.ketobrick.com/Subscribe to the podcast: https://open.spotify.com/show/42cjJssghqD01bdWBxRYEg?si=1XYKmPXmR4eKw2O9gGCEuQChapters:0:00 - How Much Muscle REALLY Boosts Your Metabolism1:21 - From Family Tragedy to Fitness Coach: Martin's Origin Story3:02 - Why High-Achievers Neglect Their Health (& How to Fix It)5:08 - The "All-or-Nothing" Trap That Keeps You Unfit7:10 - Do You Actually Need to Spend Hours in the Gym?8:28 - Stop Focusing on The Pebbles: The "Big Rocks" of Fitness9:48 - A Bodybuilder's Confession: My Battle with Binge Eating12:39 - The Vicious Cycle of Punishing Yourself in the Gym14:01 - The Unspoken Truth About Natural Bodybuilding & Health15:59 - Fat Loss vs. Muscle Gain: What Should You Focus On First?17:07 - Why The Mental & Emotional Benefits of Fitness Outweigh The Physical19:39 - Is Tracking Your Food a Necessary Evil for Results?21:30 - Why Carnivore Dieters Stop Seeing Results (And Gain Weight)22:37 - The #1 Most Overlooked Factor for Diet Success23:35 - The Simple Habit-Building Process Most People Ignore25:40 - "When Was The Last Time You Were Consistent for a Full Year?"29:00 - The "Adding, Not Subtracting" Method for Sustainable Fat Loss31:10 - Why You Should Focus on a "Building Phase" (Even if You're Overweight)34:03 - The Truth About How Strength Training Impacts Your Metabolism35:04 - Living in Abundance vs. Scarcity to Fuel Your Body36:30 - How to Shift Your Mindset from Aesthetics to Performance38:12 - Why Your Leanest Physique Isn't Your Healthiest Physique40:15 - Why Muscle Is The Ultimate "Longevity Organ"41:29 - The Biggest Obstacle High-Achieving Clients Face44:08 - The "Never Miss Twice" Rule for Unstoppable Consistency46:40 - The Best Apps for Tracking Fitness & Nutrition48:48 - A Coach's Ideal Body Fat Percentage for Health & Performance50:22 - Is a Full-Body MRI Worth The Investment for Your Health?51:36 - Your Health is The Foundation of All Ambition51:52 - Where to Find More from Martin Silva

In this special edition on Obesity as a Chronic Disease our host, Dr. Neil Skolnik will discuss the approach to treatment of obesity. This special episode is supported by an independent educational grant from Lilly. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Robert Kushner, M.D, Professor Emeritus of Medicine and Medical Education, Northwestern University Feinberg School of Medicine, former Director of the Center for Lifestyle Medicine at Northwestern Medicine, Chicago, IL.  Past-President of The Obesity Society, the American Society for Parenteral and Enteral Nutrition (ASPEN), the American Board of Physician Nutrition Specialists (ABPNS), and a founder and past-Chair of the American Board of Obesity Medicine (ABOM). Reference: Developed by the Obesity Association's Professional Practice Committee, with input and support from multiple obesity and medical organizations, The Standards of Care in Overweight and Obesity offers a groundbreaking roadmap to empower health care professionals with the tools necessary to deliver the best possible evidence-based, pragmatic care to people with overweight and obesity.

GLP-1 medications like Ozempic, Wegovy, and Tirzepatide are becoming increasingly popular for rapid weight loss - but are they the right solution for active women who care about body composition, strength, and long-term sustainability?In this episode, we break down what these medications actually do, who they're designed for, and the potential risks that often get overlooked - especially for women 35+ navigating fat loss, performance, and hormone changes.This is not about fear or judgment- it's about understanding the full picture so you can make informed decisions about your body.What You'll Learn in This EpisodeWhy GLP-1 medications are so appealing for fat lossWhat these drugs actually do in the body (and what they don't do)Who truly benefits most from GLP-1 medicationsThe difference between adherence vs dependenceThe risk of muscle loss during rapid weight lossHow under-eating can negatively impact performance and recoveryWhy many women experience rebound weight gain after stoppingThe return of hunger and food noise post-medicationThe difference between correlation vs causation in hormone and inflammation improvementsWhy appetite suppression doesn't replace the need for nutrition and behavior skillsThe long-term sustainability and financial considerations of GLP-1 useWhen these medications can be helpful (when used appropriately)Key TakeawaysGLP-1 medications do not directly burn fat—they reduce appetite, making it easier to maintain a calorie deficitWithout intentional strength training and adequate protein intake, muscle loss is a real riskMany of the “benefits” people report (better hormones, less inflammation, more energy) are largely due to weight loss itself—not the drugIf no sustainable habits are built, coming off these medications often leads to rebound weight gain and return of food noiseLong-term success comes from building skills—not relying on appetite suppressionWho These Medications May Be Appropriate ForIndividuals with Type 2 diabetesThose with obesity and significant metabolic dysfunctionIndividuals struggling with severe food noise or binge eating patternsFor others—especially active women focused on body composition—there may be more sustainable and effective long-term approaches.References & ResearchWilding JPH, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine.Jastreboff AM, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine.Weinheimer EM, Sands LP, Campbell WW. (2010). A systematic review of the effects of weight loss on lean body mass in older adults.Murphy CH, et al. (2014). Higher protein intake preserves lean mass during weight loss in older adults.Hall KD, et al. (2016). Persistent metabolic adaptation following weight loss and implications for weight regain.

Episode Summary Irish runner and content creator Michael Fox joins Matt to discuss his unconventional path in the sport. After early success as a teenage 800m/1500m runner, Mick drifted away from athletics in his 20s - moving to Australia, gaining around 30 kg, dealing with injuries, and switching focus to cycling before eventually finding his way back to running. He recounts his return to the sport and debut at the 2018 Dublin Marathon in 2:40, followed by several frustrating blow-ups while trying to improve. During COVID lockdown he leaned heavily into high mileage, including multiple 100-mile weeks, which helped unlock a new level of endurance and led to major progress - improving to 2:33 at Belfast and eventually running 2:19 for the marathon, though not without more setbacks along the way. Mick discusses becoming somewhat mileage-obsessed, then later working with a coach to incorporate faster work and more half-marathon focused training to complement his endurance. He also shares how he balances training with running a full-time sports massage business, raising three kids, and operating on limited sleep, crediting his wife's support and occasional altitude camps as key pieces of the puzzle. The conversation also touches on social media dynamics in running, outspoken opinions online, content creation, and dealing with backlash - including reactions to his gel-fueling videos. Mick explains his process for creating content, why he continues posting despite criticism, and his recent efforts to cut back caffeine and energy drink dependence. He closes by outlining his ambitions to push his marathon PB closer to 2:16. Mick Fox Strava: https://www.strava.com/athletes/9571709 Mick Fox Instagram: https://www.instagram.com/runningfox26.2/ Be coached by Matt: https://www.sweatelitecoaching.com/coaching-2026 Join the Shareholders Club / Private Podcast Feed: https://www.sweatelite.co/shareholders Matt Instagram: https://www.instagram.com/mattinglisfox/ Matt Training Log - Strava: https://www.strava.com/athletes/6248359/ Contact Matt: matt@sweatelite.co Topics: 00:00 - Foxes On The Pod 01:04 - Early Track Years 02:15 - Drifting From Running 02:34 - Australia Weight Gain Reset 03:37 - Marathon Spark 2018 04:03 - 800m Times And Racing 05:34 - First Running Motivation 07:21 - Debut Marathon Two Forty 09:11 - Covid Mileage Breakthrough 11:58 - Training Lessons And Volume 15:46 - Speedwork And Half Focus 18:00 - Balancing Family And Training 21:37 - Outspoken Online Persona 23:03 - Favorite Creators And Takes 30:02 - Hugo Fry Transparency Debate 33:47 - Gel Video Backlash Story 40:03 - Growing Instagram Following 40:12 - How He Makes Content 40:36 - Why He Posts Anyway 42:29 - Caffeine Detox Story 46:55 - Marathon Goals And Limits 49:15 - Work Schedule Reality 52:26 - Altitude Camp Dreaming 54:13 - Kenya Training Fantasy 58:49 - Friendly Rivalry Talk 59:30 - Matt's Sub 215 Ambition 01:04:17 - Valencia Entry Tips 01:06:09 - Comeback From Injury 01:08:25 - Handling Online Backlash 01:13:14 - Wrap Up And Where To Follow

Is weight loss helping your fertility or hurting it? In this episode, I'm answering a powerful community question about weight loss while trying to conceive (TTC) & being in a calorie deficit. If you've been wondering if trying to loose weight will lower your chances of getting pregnant &/or how you can loose weight without negatively impacting your fertility, this episode is for you! Ways to work with Corinne: Join the Mind Your Hormones Method, HERE! (Use code PODCAST for 10% off!!)Mentioned in this episode: Check out GutPersonal products here & their testing packages HERE! Code CORINNE saves you 10% on supplements (& on testing!) or take the GutPersonal Quiz to find out exactly which supplements are best for your unique situation! Restore PCOS Fertility Program Submit a podcast question!FREE TRAINING! How to build a hormone-healthy, blood-sugar-balancing meal! (this is pulled directly from the 1st module of the Mind Your Hormones Method!) Access this free training, HERE!Join the Mind Your Hormones Community to connect more with me & other members of this community!Come hang out with me on Instagram: @corinneangealicaOr on TikTok: @corinneangelicaEmail Fam: Click here to get weekly emails from meMind Your Hormones Instagram: @mindyourhormones.podcast Disclaimer: always consult your doctor before taking any supplementation. This podcast is intended for educational purposes only, not to diagnose or treat any conditions. 

Overweight and obesity may cause 10% of new cancer diagnoses annually in the US. In this JAMA Review in the Translational Science series, author Neil Iyengar, MD, of Emory University discusses the biological pathways that may promote cancer in people with overweight or obesity and potential therapies with JAMA Deputy Editor Mary McDermott, MD. Related Content: Obesity and Cancer

Nutrition Nugget! Bite-sized bonus episodes offer tips, tricks and approachable science. This week, Jenn is talking about zero-calorie drinks and whether they are really the guilt-free option we have been led to believe. A well-known Copenhagen study compared four groups of people who drank a liter a day of regular soda, diet soda, milk, or water for six months, and the results were surprising enough to stop anyone mid-sip. Could a beverage with absolutely no calories still be working against your blood sugar, waistline and your metabolism? What do your gut, your pancreas, and even your taste buds have to do with it? Jenn digs into the science, questions the study's details, and shares what she has seen play out in real life with herself and her clients for years. But before you toss your diet soda or defend it to the end, you should hear what Jenn has to say about who this affects, why, and whether the calorie count on the label is telling you anywhere near the whole story. Like what you're hearing? Be sure to check out the full-length episodes of new releases every Wednesday. Have an idea for a nutrition nugget? Submit it here: https://asaladwithasideoffries.com/index.php/contact/ RESOURCES:Become a Happy Healthy Hub MemberJenn's Free Menu PlanA Salad With a Side of FriesA Salad With A Side Of Fries MerchA Salad With a Side of Fries InstagramNutrition Nugget: IQ MixCopenhagen StudyKEYWORDS: Jenn Trepeck, Nutrition Nugget, Salad With A Side Of Fries, Health Tips, Wellness Tips, Zero Calorie Drinks, Diet Soda, Artificial Sweeteners, Aspartame, Insulin Response, Blood Sugar, Weight Gain, Gut Microbiome, Metabolic Health, Calorie Counting, Sugar Cravings, Glucagon, Pancreas, Glucose, Fat Burning, Gut Bacteria, Sweet Taste Addiction, Copenhagen Study, American Journal of Clinical Nutrition, Diet Cola, Regular Soda, Sugar Soda, Milk, Water Intake, BMI, Non-Diabetic Subjects, Weight Loss, Caloric Beverages, Nutrition Research, Food Cravings, Hormones, Insulin Levels, Blood Pressure, Overweight, Obese, Beverage Choices, Wellness, Weight Management, Health Coaching, Microbiome, Nutrition Science, Zero Calorie Drinks And Weight Gain, Do Diet Sodas Cause Insulin Response

get strong Get Strong or Get Left Behind | Episode 592 Good morning. It's about 60 degrees and not chilly for once. And today we're talking about something that absolutely belongs in the survival category — strength. Not vibes.Not mindset.Not theory. Physical strength. If general physical preparedness isn't a prepping principle, I don't know what is. Strength Is a Survival Skill We love talking about food storage, water filters, and gear. But if you can't pull yourself up over something, drag weight, or move your own body under stress — that's a liability. There are real-world, life-or-death scenarios where being strong saves you. Pulling yourself up Lifting something off someone Carrying weight under fatigue Defending yourself You don't want to be a weak couch potato hoping your gear saves you. Establish Your Baseline Before you get strong, you need to know where you are. Four lifts tell you almost everything about your strength: Push press Back squat Deadlift Bench press Get your one-rep max on each. You don't need a fancy stat. But those numbers? They're honest. You can't improve what you don't measure. Three Months of Focused Training Here's the strategy. Not “go to the gym and mess around.”Not “move a little weight and scroll Instagram.” Focused, purposeful training. A three-month strength-building phase. Add weight weekly. Two to five pounds per lift if possible. That's progressive overload. You can't just coast forever. But you can: Push hard for 12 weeks Build real strength Maintain it through the year That's sustainable. Pick a real program. Starting Strength is solid. Don't invent your own random plan unless you know what you're doing. Nutrition: The Part Nobody Wants You can't slam Oreos and Diet Coke and expect muscle. You need: Adequate protein Sufficient calories Consistency For me, maintenance is around 2,800 calories. After eating in a deficit for a long time, ramping up to that is going to feel like work. Gaining strength without gaining fat? That's the sweet spot. Too skinny and weak? Bad.Overweight and sluggish? Also bad. There's a bell curve for health and longevity. Moderately strong.Proper hormones.Not obese.Not extreme bodybuilder huge. That's the lane. Why This Matters for Survival If you pack on strength, you can coast. You won't keep every pound forever, but you won't crash either if you maintain properly. Strength: Improves resilience Increases confidence Extends functional life Makes you harder to victimize This isn't vanity lifting. This is capability. If you had to pull yourself up right now, could you? That's the question. This is James from SurvivalPunk.com.DIY to survive. Amazon Item OF The Day CAP Barbell 2-Inch Olympic 7 ft Barbell Bars | Multiple Options Think this post was worth 20 cents? Consider joining The Survivalpunk Army and get access to exclusive content and discounts! Don't forget to join in on the road to 1k! Help James Survivalpunk Beat Couch Potato Mike to 1k subscribers on Youtube Want To help make sure there is a podcast Each and every week? Join us on Patreon Subscribe to the Survival Punk Survival Podcast. The most electrifying podcast on survival entertainment. Itunes Pandora RSS Spotify Like this post? Consider signing up for my email list here > Subscribe Join Our Exciting Facebook Group and get involved Survival Punk Punk's The post Get Strong or Get Left Behind | Episode 592 appeared first on Survivalpunk.

Honestly, I thought I would always struggle with being overweight and depressed. But something happened a year and a half ago that changed everything. I stopped trying to lose weight. And instead, I focused on being happy.And that one shift completely transformed me! I went from being:Overweight to losing 50 lbs.Anxious to bungee jumping off a bridgeDepressed to being the happiest and most stable I've ever been... and maintaining it all, even through the hard times! Listen in to my latest podcast: “Live More. Fear Less!” so YOU can transform into the happiest woman you've ever been! Please rate and review us at Apple Podcasts. (We hope we've earned your 5 stars!)GET MY FREE RESOURCES FOR YOUR PRESCHOOL JOURNEY:❤️ Get my FREE “Start Your Preschool” book (+ $7.95 s&h)❤️ Watch my FREE "How to Start a Local or Online Preschool" Workshop❤️ Join my Preschool All Stars membership to get mentorship, support, friendship, and training for every step of your preschool journeyFOLLOW ME ON MY MISSION:

341: Is garlic actually ok for dogs? What is the best diet for a puppy, mid life, and elderly pet? And what about spaying and neutering, is that really shortening their lifespan? Rita Hogan is here to answer all these burning questions and so much more in today's interview. Rita is a holistic pet herbalist, author of the book The Herbal Dog and host of the Dogs Are Individuals Podcast, and she is breaking down misconceptions around some of the most highly asked questions and controversial topics when it comes to your pet, such as vaccinations, deworming, and even certain pet toys that can and have killed dogs, and still continue to. You may even be giving this to your dog on a regular basis and not know it. We talk about plants that could be harmful to dogs that might be in your backyard, and she even shares her take on how often we should be feeding our furry friends, so stay tuned until the very end! Topics Discussed: → Is spaying and neutering harming or helping?→ Toxic foods for dogs no one talks about→ Natural ways to deworm and prevent fleas→ The best and worst dog toys→ What to feed your elderly dog→ Is peanut butter bad for dogs?→ Are avocados actually harming your pup?→ The proper times and number of feedings per day→ How to help your overweight dog lose weight As always, if you have any questions for the show please email us at digestthispod@gmail.com. And if you like this show, please share it, rate it, review it and subscribe to it on your favorite podcast app.  Sponsored By:  → Kasandrinos | Go to https://www.kasandrinos.com/digest and use code DIGEST for 25% off → Manukora | Head to https://manukora.com/DIGEST to get $70 off the Starter Kit → Santa Barbara Chocolate | Go to https://www.santabarbarachocolate.com/ and use code LILSIPPER for a discount sitewide! Timestamps: → 00:00:00 - Introduction → 00:05:34 - Rapid fire questions → 00:07:56 - Spay & neuter → 00:13:01 - Dog hormone health → 00:17:04 - Lifestyle & vaccination → 00:20:56 - Chronic illness in dogs → 00:27:05 - Garlic & dogs → 00:30:36 - Natural flea deterrent → 00:33:35 - Foods dogs can't eat → 00:39:21 - Doggie oral care → 00:43:21 - Dog toys → 00:45:13 - Feeding times → 00:49:31 - Digestion → 00:50:42 - Overweight dogs → 00:52:24 - Toxic plants → 00:55:17 - Puppy vs old dog food Check Out Rita Hogan: → https://www.canineherbalist.com → Dogs Are Individuals Podcast  → Instagram → Get her book, The Herbal Dog → Consulting Check Out Bethany: → Bethany's Instagram: @lilsipper → YouTube → Bethany's Website → Discounts & My Favorite Products → My Digestive Support Protein Powder → Gut Reset Book  → Get my Newsletters (Friday Finds) Learn more about your ad choices. Visit megaphone.fm/adchoices

If you've ever left a medical appointment feeling dismissed, judged, or like your body size became the diagnosis... then this episode is for you — and honestly, for your doctor too. In today's episode, we're talking about the very real stigma larger-bodied people face in health care settings—and how often weight bias gets in the way of actual care. We're joined by you, our listeners, through powerful voicemails sharing both painful and healing experiences with doctors, nurses, and other healthcare providers. From being told to “just lose weight” to finally being listened to and taken seriously, these stories highlight what's broken, what's possible, and the power of weight inclusive care.Want to support the show and get bonus episodes? Join our Patreon! https://www.patreon.com/nutritionformortalsLeave us a voicemail that may be featured on a future episode! Call us at (562)-N4M-POD1 (562-646-7631). We've got MERCH! Check it out HEREDon't want to miss any episodes in the future? Make sure to subscribe wherever you listen to podcasts!Additional Reading: Journal Articles: Weight-Inclusive vs Weight-Normative ApproachNature Med: Joint International Consensus Statement for Ending Stigma of ObesityWeight Science: Evaluating The Evidence for a Paradigm ShiftImpact of Weight Bias and Stigma on Quality of CareBMJ: Weight Stigma and Bias: Standards of Care in Overweight and ObesityObesity Stigma: Important Considerations for Public HealthPediatrics: Stigma Experienced by Children and Adolescents with Obesity Pervasiveness, Impact, and Implications of Weight Stigma Assessing Weight Stigma Interventions Systematic Review of RCTsObesity Stigma: Cases, Consequences, and Potential SolutionsWeight Discrimination and Risk of Mortality Books:Health At Every SizeIntuitive Eating Body RespectWhat We Don't Talk About When We Talk About FatFearing the Black Body This Is Body GriefThe Body Is Not An ApologyMore! Weight Neutral Provider Lead ListAssociation For Size Diversity and Health Association For Weight And Size Inclusive MedicineFor feedback or to suggest a show topic email us at nutritionformortals@gmail.comFeel free to contact our real, live nutrition counseling practice**This podcast is for information purposes only, is not a substitute for individual medical or mental health advice, and does not constitute a patient-provider relationship**

02-03-26 - WWBD - He's 90lbs Overweight And Wants To Know How Brady Deals w/Being Bigger - His Wife Wants Him To Bring Another Woman Into Their BedSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

A new Nutrients study shows that drinking 12 ounces of 100% elderberry juice daily for a week helped overweight adults activate more genes that regulate how the body uses energy after meals than a placebo Elderberry juice turned on processes that help the body manage energy better — making it easier to switch between burning carbohydrates and fat for fuel Earlier research from Washington State University showed elderberry juice improved blood sugar control, increased fat burning, and shifted energy use during meal challenges Practical tip: Aim for about 12 ounces of unsweetened, 100% elderberry juice daily for seven days. Check labels to avoid added sugars, as unsweetened juice still contains about 30 to 36 grams of natural sugar per eight-ounce serving Safety first: Never eat raw elderberries, check for medication interactions (such as immunosuppressants or diabetes drugs), and consult a healthcare provider before using if you are breastfeeding or have an autoimmune condition